RU2015143177A - Анализы и способы выбора схемы лечения для субъекта с депрессией - Google Patents

Анализы и способы выбора схемы лечения для субъекта с депрессией Download PDF

Info

Publication number
RU2015143177A
RU2015143177A RU2015143177A RU2015143177A RU2015143177A RU 2015143177 A RU2015143177 A RU 2015143177A RU 2015143177 A RU2015143177 A RU 2015143177A RU 2015143177 A RU2015143177 A RU 2015143177A RU 2015143177 A RU2015143177 A RU 2015143177A
Authority
RU
Russia
Prior art keywords
seq
snp
identified
analysis
depression
Prior art date
Application number
RU2015143177A
Other languages
English (en)
Russian (ru)
Inventor
Маурицио ФАВА
Джордж ПАПАКОСТАС
мл. Гарольд О. КОЧ
Девид КРОНЛЕЙДЖ
Original Assignee
Нестек С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/796,362 external-priority patent/US9546401B2/en
Application filed by Нестек С.А. filed Critical Нестек С.А.
Publication of RU2015143177A publication Critical patent/RU2015143177A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
RU2015143177A 2013-03-12 2014-03-11 Анализы и способы выбора схемы лечения для субъекта с депрессией RU2015143177A (ru)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361777650P 2013-03-12 2013-03-12
US13/796,362 2013-03-12
US13/796,362 US9546401B2 (en) 2011-11-14 2013-03-12 Assays and methods for selecting a treatment regimen for a subject with depression
US61/777,650 2013-03-12
US201361914338P 2013-12-10 2013-12-10
US61/914,338 2013-12-10
PCT/US2014/023695 WO2014164882A1 (en) 2013-03-12 2014-03-11 Assays and methods for selecting a treatment regimen for a subject with depression

Publications (1)

Publication Number Publication Date
RU2015143177A true RU2015143177A (ru) 2017-04-18

Family

ID=51658998

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015143177A RU2015143177A (ru) 2013-03-12 2014-03-11 Анализы и способы выбора схемы лечения для субъекта с депрессией

Country Status (12)

Country Link
EP (1) EP2973135A4 (zh)
JP (1) JP2016518816A (zh)
KR (1) KR20150131147A (zh)
CN (1) CN105518685A (zh)
AU (1) AU2014248949A1 (zh)
BR (1) BR112015022820A8 (zh)
CA (1) CA2904418A1 (zh)
IL (1) IL241156A0 (zh)
MX (1) MX2015012520A (zh)
RU (1) RU2015143177A (zh)
TW (1) TW201437635A (zh)
WO (1) WO2014164882A1 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2855706A4 (en) * 2012-06-01 2016-06-08 Brc Operations Pty Ltd BIOMARKER FOR TREATMENT RESULTS
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
CN115350200A (zh) 2014-12-08 2022-11-18 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
WO2016135707A1 (en) * 2015-02-27 2016-09-01 Nestec S.A. Diagnosis of major depressive disorder, mild cognitive impairment, and alzheimer's disease and other neurologic and psychiatric disorders
ES2950489T3 (es) 2015-10-28 2023-10-10 Glycom As Composición sintética y método para modular los trastornos de la emoción y del ánimo
EP3368046B1 (en) 2015-10-28 2022-07-27 Glycom A/S Synthetic composition and method for modulating brain function and behaviour
KR101911339B1 (ko) * 2017-07-17 2018-10-25 고려대학교 산학협력단 카테콜아민-o-메틸 전이 효소 유전자의 메틸화 비율을 이용한 우울증 진단에 관한 정보를 제공하는 방법
EP3821982B1 (en) * 2018-07-12 2024-07-10 Korea Research Institute of Bioscience and Biotechnology Substrate for nucleic acid amplification, and method for manufacturing same
CN109234383A (zh) * 2018-11-07 2019-01-18 上海康黎医学检验所有限公司 与抗精神疾病药相关的试剂盒、目标基因及其制备、snp标记、snp识别和应用
CN109966498A (zh) * 2019-03-25 2019-07-05 北京坤秋健康科技有限公司 一种抗抑郁症的药物组合物及其用途
CN111500709A (zh) * 2020-05-12 2020-08-07 珠海横琴润孚创新科技有限公司 一种代谢性疾病基因检测与临床深度数据分析方法
KR102570458B1 (ko) * 2021-01-21 2023-08-24 전남대학교산학협력단 여성의 우울증 위험도 예측용 바이오마커, 상기 바이오마커를 이용한 여성의 우울증 위험도 진단에 대한 정보제공방법 및 진단키트
JP7432190B2 (ja) 2021-03-01 2024-02-16 勝彦 山▲崎▼ 抗うつ薬抵抗性の大うつ病患者を識別するための、データの取得方法およびキット
CN116103385A (zh) * 2021-11-11 2023-05-12 中国科学院深圳理工大学(筹) 一种预测抑郁障碍患者对治疗反应的基因诊断试剂盒和系统
WO2023237305A1 (en) 2022-06-09 2023-12-14 Société des Produits Nestlé S.A. Nutritional composition comprising gos and hmos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060216737A1 (en) * 2005-03-10 2006-09-28 John Bodeau Methods for multiplex amplification
US20100304391A1 (en) * 2009-05-29 2010-12-02 Lombard Jay L Methods for assessment and treatment of depression via utilization of single nucleotide polymorphisms analysis
BR112012007345A2 (pt) * 2009-09-30 2015-09-01 Univ California E Vitapath Genetics Inc Formulação, métodos para preparar a formulação, para determinar uma quantidade de cofator para um indivíduo, para determinar um risco ou uma predisposição para uma condição remediável por cofator em um indivíduo, auxiliado por computador para fornecer um plano de recomendação nutricional personalizado para um indivíduo e comercial para fornecer um plano de recomendação nutricional personalizado para um indivíduo, ácido nucleico isolado ou um complemento do mesmo, arranjo, e, sistema de computador
WO2012061808A2 (en) * 2010-11-05 2012-05-10 Genomind, Llc Neuropsychiatric test reports
US20140088035A1 (en) * 2010-12-03 2014-03-27 The General Hospital Corporation Treating schizophrenia
MX354547B (es) * 2011-11-14 2018-03-09 Alfasigma Spa Ensayos y métodos para seleccionar un regimen de tratamiento para un sujeto con depresión.

Also Published As

Publication number Publication date
MX2015012520A (es) 2016-01-12
EP2973135A1 (en) 2016-01-20
IL241156A0 (en) 2015-11-30
CN105518685A (zh) 2016-04-20
TW201437635A (zh) 2014-10-01
JP2016518816A (ja) 2016-06-30
BR112015022820A2 (pt) 2017-07-18
WO2014164882A1 (en) 2014-10-09
BR112015022820A8 (pt) 2019-11-26
EP2973135A4 (en) 2016-11-16
CA2904418A1 (en) 2014-10-09
KR20150131147A (ko) 2015-11-24
AU2014248949A1 (en) 2015-09-10

Similar Documents

Publication Publication Date Title
RU2015143177A (ru) Анализы и способы выбора схемы лечения для субъекта с депрессией
Eynon et al. Mitochondrial biogenesis related endurance genotype score and sports performance in athletes
JP2015508281A5 (zh)
Dubertret et al. A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes
Xu et al. Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population.
CN102586408B (zh) 高血压易感基因Mfn2单核苷酸多态性位点rs3820189的检测方法及检测试剂盒
BRPI0908425B8 (pt) métodos para predizer uma predisposição para desenvolver alcoolismo, e para predizer uma resposta para o tratamento contra alcoolismo, e, uso de um antagonista do receptor de serotonina 5-ht3
Kandaswamy et al. Allelic association, DNA resequencing and copy number variation at the metabotropic glutamate receptor GRM7 gene locus in bipolar disorder
NZ580490A (en) Genetic variaints on CHR2 and CHR16 in linkage disequilibrium with rs 13387042 as markers for use in breast cancer assesment
NZ590893A (en) Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment
Akamatsu et al. Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A
McIver et al. Population-scale analysis of human microsatellites reveals novel sources of exonic variation
Takahashi et al. Meta-analysis of data from the Psychiatric Genomics Consortium and additional samples supports association of CACNA1C with risk for schizophrenia
Wang et al. Association between a microRNA binding site polymorphism in SLCO1A2 and the risk of delayed methotrexate elimination in Chinese children with acute lymphoblastic leukemia
Campbell et al. Rare coding variants of the adenosine A3 receptor are increased in autism: on the trail of the serotonin transporter regulome
Kakhki et al. Expression of suppressor of cytokine signaling 1 (SOCS1) gene dramatically increases in relapsing–remitting multiple sclerosis
Winge et al. Lack of association between filaggrin gene mutations and onset of psoriasis in childhood
Varzari et al. Analysis of polymorphisms in RIG-I-like receptor genes in German multiple sclerosis patients
Chen et al. Copy Number Variations at the Prader‐Willi Syndrome Region on Chromosome 15 and associations with Obesity in Whites
Sulovari et al. Atlas of human diseases influenced by genetic variants with extreme allele frequency differences
Gu et al. Serum micro RNA s as potential biomarkers of mandibular prognathism
Wang et al. Association of GRM4 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma in Guangxi Chinese population
Lim et al. Molecular diagnosis of congenital muscular dystrophies with defective glycosylation of alpha-dystroglycan using next-generation sequencing technology
US20210032699A1 (en) Measurement of genomic age for predicting the risk of cancer
MX2016012718A (es) Determinación de polimorfismos de un solo nucleótido útil para predecir la respuesta para rasagilina.

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20180702